Fibrobiologics Inc Share Price Today: Live Updates & Key Insights

Fibrobiologics Inc share price today is $0.703, up -3.2%. The stock opened at $0.741 against the previous close of $0.7355, with an intraday high of $0.741 and low of $0.7.

Fibrobiologics Inc Share Price Chart

Fibrobiologics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Fibrobiologics Inc Share Price Performance

$0.703 -0.032(-3.2%) FBLG at 27 Jul 2026 02:58 PM Biotechnology
Lowest Today 0.7
Highest Today 0.741
Today’s Open 0.741
Prev. Close 0.7355
52 Week High 14.40
52 Week Low 0.70
Day’s Range: Low 0.7 High 0.741
52-Week Range: Low 0.70 High 14.40
1 day return -
1 Week return -12.48
1 month return -18.68
3 month return -51.04
6 month return +86.74
1 year return +8.02
3 year return -
5 year return -
10 year return -

Fibrobiologics Inc Institutional Holdings

Vanguard Capital Management, LLC 1.28

Vanguard Group Inc 1.15

Fund Evaluation Group, LLC 0.98

Geode Capital Management, LLC 0.56

Vanguard Institutional Extnd Mkt Idx Tr 0.53

BlackRock Inc 0.47

Fidelity Extended Market Index 0.37

Renaissance Technologies Corp 0.30

Vanguard Fiduciary Trust Co 0.12

UBS Group AG 0.11

Spartan Extended Market Index Pool F 0.06

Blackrock Extended Mkt Fund CF 0.05

Extended Equity Market Fund B 0.05

Extended Equity Market Fund E 0.05

Fidelity Series Total Market Index 0.05

BlackRock Extended Equity Market Fund K 0.05

Fidelity Total Market Index 0.04

Northern Trust Extended Eq Market Idx 0.02

NT Ext Equity Mkt Index Fund - Lending 0.02

Fidelity Nasdaq Composite Index 0.02

Spartan Total Market Index Pool G 0.02

NT Ext Equity Mkt Index Fund - NL 0.02

Goss Wealth Management LLC 0.02

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Vanguard Global Advisers, LLC 0.01

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.01

Tower Research Capital LLC 0.01

Extended Equity Market Fund M 0.01

1290 VT Micro Cap K 0.00

Western Wealth Management, LLC 0.00

Royal Bank of Canada 0.00

Islay Capital Management, LLC 0.00

Advisor Group Holdings, Inc. 0.00

Coconut Grove Bank 0.00

BNP Paribas Arbitrage, SA 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Index Fund - Ld 0.00

Hanson Mcclain Inc 0.00

Wells Fargo & Co 0.00

Goldman Sachs Asset Management, L.P. 0.00

Fibrobiologics Inc Market Status

Strong Buy: 1

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fibrobiologics Inc Fundamentals

Market Cap 3.83 M

PB Ratio 1.733

PE Ratio 0.0

Enterprise Value 5.50 M

Total Assets 9.62 M

Volume 52376

Fibrobiologics Inc Company Financials

Annual Revenue FY26:0 0.0M, FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M

Annual Profit FY26:-832000 -0.8M, FY25:-573000 -0.6M, FY24:-437000 -0.4M, FY23:null 0.0M

Annual Net worth FY26:-18646000 -18.6M, FY25:-11161000 -11.2M, FY24:-16485000 -16.5M, FY23:-5121000 -5.1M

Quarterly Revenue Q1/2026:0 0.0M, Q4/2025:null 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q4/2025:231000 0.2M, Q3/2025:-231000 -0.2M, Q2/2025:-206000 -0.2M, Q1/2025:null 0.0M

Quarterly Net worth Q1/2026:-5000000 -5.0M, Q4/2025:-3244000 -3.2M, Q3/2025:-5778000 -5.8M, Q2/2025:-4658000 -4.7M, Q1/2025:-4966000 -5.0M

About Fibrobiologics Inc & investment objective

Company Information FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Organisation Biotechnology

Employees 15

Industry Biotechnology

CEO Mr. Peter O'Heeron

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Fibrobiologics Inc FAQs

What is the share price of Fibrobiologics Inc today?

The current share price of Fibrobiologics Inc is $0.703.

Can I buy Fibrobiologics Inc shares in India?

Yes, Indian investors can buy Fibrobiologics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Fibrobiologics Inc shares in India?

You can easily invest in Fibrobiologics Inc shares from India by:

Can I buy fractional shares of Fibrobiologics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Fibrobiologics Inc?

Fibrobiologics Inc has a market cap of $3.83 M.

In which sector does Fibrobiologics Inc belong?

Fibrobiologics Inc operates in the Biotechnology sector.

What documents are required to invest in Fibrobiologics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Fibrobiologics Inc?

The PE ratio of Fibrobiologics Inc is N/A and the PB ratio is 1.73.